347 related articles for article (PubMed ID: 22763434)
21. The E3 ligase Cbl-b and TAM receptors regulate cancer metastasis via natural killer cells.
Paolino M; Choidas A; Wallner S; Pranjic B; Uribesalgo I; Loeser S; Jamieson AM; Langdon WY; Ikeda F; Fededa JP; Cronin SJ; Nitsch R; Schultz-Fademrecht C; Eickhoff J; Menninger S; Unger A; Torka R; Gruber T; Hinterleitner R; Baier G; Wolf D; Ullrich A; Klebl BM; Penninger JM
Nature; 2014 Mar; 507(7493):508-12. PubMed ID: 24553136
[TBL] [Abstract][Full Text] [Related]
22. K33-linked polyubiquitination of T cell receptor-zeta regulates proteolysis-independent T cell signaling.
Huang H; Jeon MS; Liao L; Yang C; Elly C; Yates JR; Liu YC
Immunity; 2010 Jul; 33(1):60-70. PubMed ID: 20637659
[TBL] [Abstract][Full Text] [Related]
23. Cbl-b regulates the CD28 dependence of T-cell activation.
Chiang YJ; Kole HK; Brown K; Naramura M; Fukuhara S; Hu RJ; Jang IK; Gutkind JS; Shevach E; Gu H
Nature; 2000 Jan; 403(6766):216-20. PubMed ID: 10646609
[TBL] [Abstract][Full Text] [Related]
24. Regulation of PTEN/Akt and MAP kinase signaling pathways by the ubiquitin ligase activators Ndfip1 and Ndfip2.
Mund T; Pelham HR
Proc Natl Acad Sci U S A; 2010 Jun; 107(25):11429-34. PubMed ID: 20534535
[TBL] [Abstract][Full Text] [Related]
25. Cutting edge: regulation of T cell activation threshold by CD28 costimulation through targeting Cbl-b for ubiquitination.
Zhang J; Bárdos T; Li D; Gál I; Vermes C; Xu J; Mikecz K; Finnegan A; Lipkowitz S; Glant TT
J Immunol; 2002 Sep; 169(5):2236-40. PubMed ID: 12193687
[TBL] [Abstract][Full Text] [Related]
26. Cbl enforces an SLP76-dependent signaling pathway for T cell differentiation.
Chiang YJ; Jordan MS; Horai R; Schwartzberg PL; Koretzky GA; Hodes RJ
J Biol Chem; 2009 Feb; 284(7):4429-38. PubMed ID: 19074136
[TBL] [Abstract][Full Text] [Related]
27. Cutting edge: Cbl-b: one of the key molecules tuning CD28- and CTLA-4-mediated T cell costimulation.
Li D; Gál I; Vermes C; Alegre ML; Chong AS; Chen L; Shao Q; Adarichev V; Xu X; Koreny T; Mikecz K; Finnegan A; Glant TT; Zhang J
J Immunol; 2004 Dec; 173(12):7135-9. PubMed ID: 15585834
[TBL] [Abstract][Full Text] [Related]
28. The ubiquitin E3 ligase Nedd4-1 controls neurite development.
Kawabe H; Brose N
Cell Cycle; 2010 Jul; 9(13):2477-8. PubMed ID: 20543564
[No Abstract] [Full Text] [Related]
29. Activation of T cells: releasing the brakes by proteolytic elimination of Cbl-b.
Schmitz ML
Sci Signal; 2009 Jun; 2(76):pe38. PubMed ID: 19549983
[TBL] [Abstract][Full Text] [Related]
30. The E3 ubiquitin ligase Cbl-b regulates expansion but not functional activity of self-reactive CD4 T cells.
St Rose MC; Qui HZ; Bandyopadhyay S; Mihalyo MA; Hagymasi AT; Clark RB; Adler AJ
J Immunol; 2009 Oct; 183(8):4975-83. PubMed ID: 19801520
[TBL] [Abstract][Full Text] [Related]
31. Oncogenic role of the E3 ubiquitin ligase NEDD4-1, a PTEN negative regulator, in non-small-cell lung carcinomas.
Amodio N; Scrima M; Palaia L; Salman AN; Quintiero A; Franco R; Botti G; Pirozzi P; Rocco G; De Rosa N; Viglietto G
Am J Pathol; 2010 Nov; 177(5):2622-34. PubMed ID: 20889565
[TBL] [Abstract][Full Text] [Related]
32. Ubiquitin-dependent regulation of phospho-AKT dynamics by the ubiquitin E3 ligase, NEDD4-1, in the insulin-like growth factor-1 response.
Fan CD; Lum MA; Xu C; Black JD; Wang X
J Biol Chem; 2013 Jan; 288(3):1674-84. PubMed ID: 23195959
[TBL] [Abstract][Full Text] [Related]
33. E3 ubiquitin ligase Cbl-b in innate and adaptive immunity.
Liu Q; Zhou H; Langdon WY; Zhang J
Cell Cycle; 2014; 13(12):1875-84. PubMed ID: 24875217
[TBL] [Abstract][Full Text] [Related]
34. NEDD4-1 is a proto-oncogenic ubiquitin ligase for PTEN.
Wang X; Trotman LC; Koppie T; Alimonti A; Chen Z; Gao Z; Wang J; Erdjument-Bromage H; Tempst P; Cordon-Cardo C; Pandolfi PP; Jiang X
Cell; 2007 Jan; 128(1):129-39. PubMed ID: 17218260
[TBL] [Abstract][Full Text] [Related]
35. The role of the e3 ligase cbl-B in murine dendritic cells.
Wallner S; Lutz-Nicoladoni C; Tripp CH; Gastl G; Baier G; Penninger JM; Stoitzner P; Wolf D
PLoS One; 2013; 8(6):e65178. PubMed ID: 23762309
[TBL] [Abstract][Full Text] [Related]
36. The E3 Ubiquitin Ligase c-Cbl Inhibits Microglia-Mediated CNS Inflammation by Regulating PI3K/Akt/NF-κB Pathway.
Dong L; Li YZ; An HT; Wang YL; Chen SH; Qian YJ; Wang K; Zhen JL; Fan Z; Gong XL; Zheng Y; Wang XM
CNS Neurosci Ther; 2016 Aug; 22(8):661-9. PubMed ID: 27156691
[TBL] [Abstract][Full Text] [Related]
37. CD28 activation does not down-regulate Cbl-b expression in aged rat T-lymphocytes.
Xu Z; George C; Jolly CA
Mech Ageing Dev; 2004 Sep; 125(9):595-602. PubMed ID: 15491677
[TBL] [Abstract][Full Text] [Related]
38. Lys63-polyubiquitination by the E3 ligase casitas B-lineage lymphoma-b (Cbl-b) modulates peripheral regulatory T cell tolerance in patients with systemic lupus erythematosus.
Romo-Tena J; Rajme-López S; Aparicio-Vera L; Alcocer-Varela J; Gómez-Martín D
Clin Exp Immunol; 2018 Jan; 191(1):42-49. PubMed ID: 28940360
[TBL] [Abstract][Full Text] [Related]
39. SLAP2 Adaptor Binding Disrupts c-CBL Autoinhibition to Activate Ubiquitin Ligase Function.
Wybenga-Groot LE; Tench AJ; Simpson CD; Germain JS; Raught B; Moran MF; McGlade CJ
J Mol Biol; 2021 Apr; 433(8):166880. PubMed ID: 33617900
[TBL] [Abstract][Full Text] [Related]
40. Degradation of Bcl10 induced by T-cell activation negatively regulates NF-kappa B signaling.
Scharschmidt E; Wegener E; Heissmeyer V; Rao A; Krappmann D
Mol Cell Biol; 2004 May; 24(9):3860-73. PubMed ID: 15082780
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
